White House Delays Permanent CDC Director Nomination; Bhattacharya Remains Acting CDC Director

The White House has indefinitely delayed the selection of a permanent CDC director, allowing NIH Director Jay Bhattacharya to continue serving as acting head of the agency despite reaching a federally mandated deadline.

“Skip to main content 4 hours ago - Health White House delays permanent CDC director pick Peter Sullivan email (opens in new window) sms (opens in new window) facebook (opens in new window) twitter (opens in new window) linkedin (opens in new window) bluesky (opens in new window) Add Axios as your preferred source to see more of our stories on Google”

Axios

According to Healio, the Vacancies Reform Act limits the length of time executive branch positions can be filled in an acting capacity to 210 days, with the clock beginning when Jim O'Neill was named acting director on August 29.

Healio

Axios reports that the administration faced a Thursday statutory deadline for Bhattacharya to continue serving as acting CDC head without nominating a permanent replacement.

Bhattacharya will continue performing duties connected with the CDC post without officially holding the position, according to Axios.

NBC News provides context that Bhattacharya has been leading the agency for just over a month, replacing O'Neill who served as acting director for five-plus months after Susan Monarez was fired.

The CDC leadership vacuum stems from recent turmoil within the agency, including the firing of Susan Monarez and subsequent mass resignations of key officials.

NBC News reports that Monarez was fired because she refused to cave to Health Secretary Robert F. Kennedy Jr.'s demands to rubber-stamp vaccine recommendations without scientific backing.

NBC News

This firing led to resignations including the chief medical officer Dr. Debra Houry, Dr. Daniel Jernigan who headed the National Center for Emerging and Zoonotic Infectious Diseases, and Daskalakis.

Healio notes that Monarez was the only person to hold the title of CDC director during Trump's second term, filling the position for just 29 days last summer.

Axios adds that before Trump's second term, presidents simply named their own CDC directors and didn't need Senate approval, but this changed with the CDC Leadership Accountability Act of 2023.

The White House delay represents a strategic approach to navigating confirmation challenges while maintaining administrative objectives.

“The White House won’t meet an expected Wednesday deadline to nominate a new director of the Centers for Disease Control and Prevention”

NBC News

Axios reports that the situation 'underscores the difficulty of finding a nominee who can be confirmed by the Senate and leaves the beleaguered public health agency without a full-time political leader.'

The administration appears to be balancing its objective of 'restoring the CDC to its original mission of fighting infectious disease' with the need to find someone who can effectively work with Health Secretary Robert F. Kennedy Jr.

Healio quotes White House spokesperson Kush Desai stating that 'restoring competence and confidence in CDC decision-making remains a top priority for the White House after the Biden administration's COVID excesses,' suggesting a deliberate shift in public health priorities.

Axios also notes that the delay 'gives the administration a chance to continue pivoting away from controversial policies on vaccines ahead of the midterm elections,' indicating political timing considerations.

The prolonged leadership vacuum is creating significant operational challenges within the CDC, affecting daily functions and long-term projects.

NBC News reports that 'projects have floundered, many in a holding pattern awaiting funding' and that 'things sit on people's desks for months, just waiting for the director's office to sign off.'

NBC News

The article further notes that 'supplies are expiring or getting thrown out as staff members wait for word on whether work can move forward,' creating tangible consequences from the delay.

Axios confirms that Bhattacharya, who also serves as director of the National Institutes of Health, will continue performing duties connected with the CDC post, though the dual role may present resource allocation challenges.

Healio quotes Desai stating that 'Dr. Jay Bhattacharya's leadership at the CDC is a great service to the country, and he has now been delegated to provide continuity in day-to-day CDC processes until the White House nominates a permanent CDC director in short order,' suggesting the administration views the current arrangement as temporary but necessary.